This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adams, V. Articles by Hambrecht, R. Search for Related Content PubMed PubMed Citation Articles by Adams, V. Articles by Hambrecht, R.

CLINICAL STUDIES

Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance

^a Clinic for Internal Medicine/Cardiology, University of Leipzig, Herzzentrum GmbH, Leipzig, Germany

Manuscript received July 9, 1998; revised manuscript received October 14, 1998, accepted November 18, 1998.

Reprint requests and correspondence: Dr. Volker Adams, Universität Leipzig, Herzzentrum GmbH, Klinik für Innere Medizin/Kardiologie, Russenstrasse 19, D-04289 Leipzig, Germany
adav{at}server3.medizin.uni-leipzig.de

OBJECTIVES

The purpose of the study was to investigate if apoptosis occurs in skeletal muscle myocytes and its relation to exercise intolerance in patients with chronic heart failure (CHF).

BACKGROUND

Intrinsic abnormalities of skeletal muscle frequently limit exercise tolerance in CHF patients. Recently, apoptosis has been detected in cardiac myocytes of patients with CHF, suggesting that apoptosis may contribute to the reduced contractile force. The presence and regulation of apoptosis in skeletal myocytes of patients with CHF remains to be defined.

METHODS

Skeletal muscle biopsies (m. vastus lateralis) of 34 CHF patients (New York Heart Association functional class II–III) and eight age-matched healthy control subjects were analyzed by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling for the presence of apoptosis, and by immunohistochemistry and videodensitometrical quantification for inducible nitric oxide synthase (iNOS) and Bcl-2 expression. Maximal oxygen consumption (VO₂max) was determined by ergospirometry.

RESULTS

Apoptosis was detected in 16/34 (47%) patients with CHF and in none of the healthy subjects. Patients with apoptosis-positive skeletal muscle myocytes exhibited a significantly lower VO₂max (12.0 ± 3.7 vs. 18.2 ± 4.4 ml/kg/min; p = 0.0005), a higher iNOS expression (6.8 ± 3.6 vs. 3.7 ± 2.6% iNOS-positive stained tissue area; p = 0.015) and a lower Bcl-2 expression (1.0 ± 0.3 vs. 1.4 ± 0.4% Bcl-2–positive tissue area; p = 0.03) as compared with patients with apoptosis-negative biopsies.

CONCLUSIONS

These results indicate that apoptosis is frequently found in skeletal muscle obtained from CHF patients, which is associated with significant impairment of functional work capacity. In skeletal muscle of these patients, iNOS and Bcl-2 are possibly involved in the regulation of apoptosis.

Abbreviations and Acronyms   CHF = chronic heart failure   iNOS = inducible nitric oxide synthase   NO = nitric oxide   RT = room temperature   TdT = terminal deoxynucleotidyl transferase   TUNEL = terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling

This article has been cited by other articles:

				R. G. Mitchell, B. D. Duscha, J. L. Robbins, S. I. Redfern, J. Chung, D. R. Bensimhon, W. E. Kraus, W. R. Hiatt, J. G. Regensteiner, and B. H. Annex Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 285 - 290. [Abstract] [PDF]

				J. M. McClung, A. N. Kavazis, K. C. DeRuisseau, D. J. Falk, M. A. Deering, Y. Lee, T. Sugiura, and S. K. Powers Caspase-3 Regulation of Diaphragm Myonuclear Domain during Mechanical Ventilation-induced Atrophy Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 150 - 159. [Abstract] [Full Text] [PDF]

				W Doehner and S D Anker Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure? Heart, June 1, 2005; 91(6): 707 - 709. [Abstract] [Full Text] [PDF]

				C. Leeuwenburgh, C. M. Gurley, B. A. Strotman, and E. E. Dupont-Versteegden Age-related differences in apoptosis with disuse atrophy in soleus muscle Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1288 - R1296. [Abstract] [Full Text] [PDF]

				A. Linke, V. Adams, P. C. Schulze, S. Erbs, S. Gielen, E. Fiehn, S. Mobius-Winkler, A. Schubert, G. Schuler, and R. Hambrecht Antioxidative Effects of Exercise Training in Patients With Chronic Heart Failure: Increase in Radical Scavenger Enzyme Activity in Skeletal Muscle Circulation, April 12, 2005; 111(14): 1763 - 1770. [Abstract] [Full Text] [PDF]

				I. Navarro-Lerida, M. T. Portoles, A. A. Barrientos, F. Gavilanes, L. Bosca, and I. Rodriguez-Crespo Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels J. Cell Sci., May 1, 2004; 117(9): 1687 - 1697. [Abstract] [Full Text] [PDF]

				C. Leeuwenburgh Role of Apoptosis in Sarcopenia J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2003; 58(11): M999 - 1001. [Abstract] [Full Text] [PDF]

				D. L. Mann and M. B. Reid Exercise training and skeletal muscle inflammation in chronic heart failure: feeling better about fatigue J. Am. Coll. Cardiol., September 3, 2003; 42(5): 869 - 872. [Full Text] [PDF]

				R. Persinger, Y. Janssen-Heininger, S. S. Wing, D. E. Matthews, M. M. LeWinter, and M. J. Toth Effect of heart failure on the regulation of skeletal muscle protein synthesis, breakdown, and apoptosis Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E1001 - E1008. [Abstract] [Full Text] [PDF]

				A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets Systemic effects of chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2003; 21(2): 347 - 360. [Abstract] [Full Text] [PDF]

				V.M. Conraads, P. Beckers, J. Bosmans, L.S. De Clerck, W.J. Stevens, C.J. Vrints, and D.L. Brutsaert Combined endurance/resistance training reduces plasma TNF-{alpha} receptor levels in patients with chronic heart failure and coronary artery disease Eur. Heart J., December 1, 2002; 23(23): 1854 - 1860. [Abstract] [Full Text] [PDF]

				A. G. N. Agusti, J. Sauleda, C. Miralles, C. Gomez, B. Togores, E. Sala, S. Batle, and X. Busquets Skeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 485 - 489. [Abstract] [Full Text] [PDF]

				R. Hambrecht, P. C. Schulze, S. Gielen, A. Linke, S. Mobius-Winkler, J. Yu, J.u. Kratzsch, G. Baldauf, M. W. Busse, A. Schubert, et al. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1175 - 1181. [Abstract] [Full Text] [PDF]

				R Sharma and S.D Anker From tissue wasting to cachexia: changes in peripheral blood flow and skeletal musculature Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D12 - D17. [Abstract] [PDF]

				M. Cicoira, L. Zanolla, L. Franceschini, A. Rossi, G. Golia, M. Zamboni, P. Tosoni, and P. Zardini Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2080 - 2085. [Abstract] [Full Text] [PDF]

				J. S. Stamler and G. Meissner Physiology of Nitric Oxide in Skeletal Muscle Physiol Rev, January 1, 2001; 81(1): 209 - 237. [Abstract] [Full Text] [PDF]

				J. Marin-Garcia, M. J Goldenthal, and G. W Moe Mitochondrial pathology in cardiac failure Cardiovasc Res, January 1, 2001; 49(1): 17 - 26. [Full Text] [PDF]

				G Vescovo, M Volterrani, R Zennaro, M Sandri, C Ceconi, R Lorusso, R Ferrari, G B Ambrosio, and L Dalla Libera Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes Heart, October 1, 2000; 84(4): 431 - 437. [Abstract] [Full Text]

				D. M. Weinstein, M. J. Mihm, and J. A. Bauer Cardiac Peroxynitrite Formation and Left Ventricular Dysfunction following Doxorubicin Treatment in Mice J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 396 - 401. [Abstract] [Full Text]

				A. Dirks and C. Leeuwenburgh Apoptosis in skeletal muscle with aging Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R519 - R527. [Abstract] [Full Text] [PDF]